Clinical Trial Update: NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the NanoCross BTK 0.014 balloon catheter for infrapopliteal lesions in peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• NanoCross BTK 0.014 Balloon Catheter

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED